Carvacrol nanoemulsion (25, 50 and 100 μg/mL) also decreased ROS and regulated apoptosis via p‐JNK, Bax and Bcl2 and increased Cyt c and activated Cas cascades in human lung adenocarcinoma A549 cells. This evidence concerns the gene BAX and lung adenocarcinoma.